ArticlebioRxiv : the preprint server for biology2026
Sequence constraints predispose Class D GPCRs to follow an atypical activation mechanism.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The biophysical principles underlying distinct conformational changes in proteins with similar topologies remain poorly understood. Class D G Protein-Coupled Receptors (GPCRs), fungal pheromone-sensing receptors essential for mating and survival, exhibit an atypical activation mechanism compared to other GPCR classes. Unlike Class A GPCRs, which activate through outward movement of TM6, Class D receptors undergo activation via outward displacement of TM7 coupled with inward movement of TM6. To investigate the origin of this atypical process, we employed state-specific generative AI sequence models to design protein sequences corresponding to unique active states, revealing that sequence constraints predispose Class D GPCRs toward this mechanism. We further explored the dynamic basis of activation through millisecond-scale atomistic simulations of STE2, a representative Class D GPCR and therapeutic target for fungal diseases. Using Maximum Entropy VAMPNets, an active learning based adaptive sampling strategy, we efficiently mapped the conformational free energy landscape of STE2. These simulations uncovered multiple intermediate states that have not yet been resolved experimentally and demonstrated that activation in these dimeric proteins involves fully decoupled monomers. Comparative simulations across Classes A, B, D, and F, totaling 4 milliseconds of all-atom molecular dynamics, revealed distinct patterns of electrostatic interactions. In Class D GPCRs, activation disrupts a dense TM7 interaction network while inward TM6 movement enhances electrostatic contacts. In contrast, Class A GPCRs such as CB1R display the opposite trend. Together, these findings show that sequence differences in TM6 and TM7 underlie the unique activation mechanism of STE2, offering new insights into GPCR conformational diversity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.